Futura Medical (LON:FUM) Stock Price Down 21.1% – Should You Sell?

Shares of Futura Medical plc (LON:FUM) were down 21.1% during trading on Monday . The stock traded as low as GBX 0.31 and last traded at GBX 0.35. Approximately 3,753,080 shares were traded during trading, a decline of 63% from the average session volume of 10,207,083 shares. The stock had previously closed at GBX 0.45.

Futura Medical Trading Down 21.1%

The stock has a market cap of £2.06 million, a P/E ratio of -0.13 and a beta of 0.02. The firm’s fifty day moving average is GBX 0.58 and its 200 day moving average is GBX 0.99.

Futura Medical (LON:FUM) last released its quarterly earnings results on Wednesday, April 29th. The company reported GBX (2.78) earnings per share (EPS) for the quarter. The firm had revenue of GBX 170 million for the quarter. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%. Research analysts forecast that Futura Medical plc will post 2.8486672 earnings per share for the current fiscal year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.